Dernières nouvelles pour Savara (NASDAQ:SVRA) Stock

SAVARA INC

Savara

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Inc

Amazon.com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) cloud unit chief acknowledged the company&#8217;s aggressive expansion of server farms globally and boost of access to the latest artificial intelligence chips from&nbsp;Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Amazon Web Services (AWS) opened a cluster of data centers in Mexico in 2025, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-05-30/amazon-pledges-to-continue-aggressive-data-center-expansion" target="_blank" rel="noreferrer noopener">reported</a> on Friday, citing AWS CEO Matt Garman&#8216;s interview.
Garman told Bloomberg that the cloud division is also building new facilities in Chile, New Zealand, Saudi Arabia and Taiwan.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/05/45673288/when-nvidia-wins-broadcom-climbs-ai-boom-sends-chip-stocks-soaring" rel="noreferrer noopener">When Nvidia Wins, Broadcom Climbs: AI Boom Sends Chip Stocks Soaring</a>
Garman also acknowledged strong demand. He said AWS was working with Nvidia to expand its stock of the latter&#8217;s latest GB200 semiconductors, which are available for AWS customers to test.
Garman expressed appreciation for the opportunity to host OpenAI&#8217;s models on AWS. Recently, OpenAI received permission to explore other partnerships beyond Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
Wells Fargo analysts said in April that Amazon had paused some of its data center leasing talks, especially in international markets, following a similar move by Microsoft.
Microsoft abandoned data center projects in the U.S. and Europe due to an oversupply of electricity relative to current demand forecasts.
Subsequently, executives from&nbsp;Amazon and&nbsp;Nvidia <a target="_blank" href="https://www.benzinga.com/25/04/45001873/amazon-and-nvidia-dismiss-fears-of-ai-data-center-pullback-we-continue-to-see-very-strong-demand" rel="noreferrer noopener">dismissed concerns about</a> a potential slowdown in constructing AI data centers.
Price Action: AMZN stock was down 1.46% at $202.65 at last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45565087/cramer-backs-marvell-again-as-ai-deals-with-amazon-microsoft-fuel-stock-surge" target="_blank" rel="noreferrer noopener">Cramer Backs Marvell Again As AI Deals With Amazon, Microsoft Fuel Stock Surge</a></li>
</ul>
Photo: Shutterstock

Tech

AMZN

MSFT

NVDA

Amazon Expands Global Data Centers, Boosts Access To Nvidia AI Chips For Cloud Customers

Shares of Mullen Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) tumbled 25.4% to $0.08 on Friday afternoon, extending recent losses following the company's announcement of a 1-for-100 reverse stock split.
What To Know: The electric vehicle manufacturer <a href="https://www.benzinga.com/news/stock-split/25/05/45679654/mullen-automotive-stock-is-tumbling-thursday-whats-driving-the-action">aims to regain compliance</a> with Nasdaq's $1.00 minimum bid price requirement through the reverse split, which will take effect at 12:01 a.m. ET on June 2.
Approved by shareholders at a May 21 special meeting, the split will consolidate every 100 shares of Mullen&#8217;s common stock into a single share. The move will reduce the number of outstanding shares from approximately 80 million to about 800,000. While no fractional shares will be issued, any fractional holdings will be rounded up.
Mullen&#8217;s common stock will continue trading under the symbol &#8220;MULN&#8221; on a split-adjusted basis starting June 2. However, the company cautioned that there is no guarantee the split will bring shares above the $1.00 threshold required for continued Nasdaq listing.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45700679/rivian-rivn-stock-is-volatile-whats-going-on">Rivian Stock Is Volatile: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy MULN Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Mullen Automotive&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MULN has a 52-week high of $2,867,995.30 and a 52-week low of $0.075.

News

MULN

Mullen Automotive (MULN) Shares Plunge 25% Amid Reverse Stock Split Plans

Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) stock surged on Friday amid reports indicating the Trump administration has <a target="_blank" href="https://www.benzinga.com/topic/palantir" rel="noreferrer noopener">expanded the company's</a> work across the federal government in recent months.
Palantir is also discussing buying its technology with the Social Security Administration and the Internal Revenue Service (IRS), the New York Times <a target="_blank" href="https://www.nytimes.com/2025/05/30/technology/trump-palantir-data-americans.html" rel="noreferrer noopener">reported</a> on Friday, citing six government officials and Palantir employees familiar with the matter.
According to the report, Palantir has secured more than $113 million in contracts (new and additional funds from existing) since Trump took office. This does not include the $795 million DoD contract awarfed last week.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45655507/tech-analyst-expects-palantir-stock-to-rise-above-400-as-ai-revolution-kicks-into-gear" rel="noreferrer noopener">Tech Analyst Expects Palantir Stock To Rise Above $400 As AI Revolution Kicks Into Gear</a>
In March, President Trump signed an executive order directing federal agencies to enhance data sharing, effectively introducing Palantir's key platform, Foundry, to at least four agencies, including DHS and the Department of Health and Human Services.
The Trump administration&nbsp;has also pursued access to various data points on citizens and others through government databases and bank accounts, the report said.
Palantir's government contracts span the Defense Department and Centers for Disease Control and Prevention.
Palantir stock has 75% year-to-date and 504% in the last 12 months.
Palantir is in discussions for a permanent contract with the IRS after joining them in April to organize data, the New York Times cited government officials familiar with the matter.
Palantir also recently began helping Immigration and Customs Enforcement's enforcement and removal operations team under a $30 million deal they inked in April, the New York Times cited Palantir employees and DHS officials familiar with the matter.
Palantir also discussed organizing the Social Security Administration and the Department of Education's data, the New York Times reported, citing Palantir employees and officials in those agencies.
Price Action: PLTR stock is up 3.51% at $126.80 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/05/45692725/alibaba-and-baidu-turn-to-chinese-ai-chips-as-us-sanctions-squeeze-nvidia-supply" target="_blank" rel="noreferrer noopener">Alibaba And Baidu Turn To Chinese AI Chips As US Sanctions Squeeze Nvidia Supply</a></li>
</ul>
Photo via Shutterstock

Government

PLTR

Palantir Stock Gains As Trump Expands Company's Role in US Government Agencies

Macro Economic Events

Global

Economics

Reuters Reports Japan Economy Minister Akazawa Reportedly Says, Aware Of Comments By Trump And Others On Nippon Steel Deal For U.S. Steel, Waiting For Official Announcement Of Terms

Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">slightly higher on Friday</a>.
On Thursday, the company reported first-quarter adjusted earnings per share of $1.60, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45674314/burlington-beats-q1-earnings-ceo-vows-to-absorb-tariff-heat-through-gains-elsewhere" rel="noreferrer noopener">analyst consensus estimate of $1.41</a>. Quarterly sales of $2.50 billion missed the Street view of $2.52 billion.
The company&#8217;s CEO, Michael O&#8217;Sullivan, stated that while tariffs are expected to significantly impact merchandise margins, he is confident the company can offset this pressure in other areas of the profit and loss statement, provided tariffs do not rise beyond current levels.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45697301/shoe-carnival-stockpiles-inventory-to-dodge-tariffs-ramps-up-rebannering" rel="noreferrer noopener">Shoe Carnival Stockpiles Inventory To Dodge Tariffs, Ramps Up Rebannering</a>
Here are the <a target="_blank" href="https://www.benzinga.com/quote/BURL/analyst-ratings" rel="noreferrer noopener">key analysts&#8217; views</a> on the company:
Telsey Advisory Group analyst Dana Telsey reiterated the Outperform rating on Burlington, lowering the price forecast from $340 to $300.
In an analyst note, Telsey noted that acquiring prime retail locations remains a key part of Burlington&#8217;s strategy to expand its footprint and draw in high-value customers, especially as consumers increasingly prioritize value.
However, due to macroeconomic uncertainty and rising costs tied to acquiring leases from bankrupt retailers, Telsey lowered the firm&#8217;s price forecast.
She highlighted that Burlington is adjusting its strategy and staying agile in response to current conditions.
While tariffs are creating short-term challenges, management believes it won&#8217;t cause lasting structural shifts in the retail sector.
The company&#8217;s FY25 outlook factors in a 30% tariff on imports from China and 10% on goods from other countries.
To reduce its reliance on China, Burlington is collaborating with vendors and sourcing more products already located in the U.S., Telsey noted.
She added that the company has several levers across the cost of goods sold and SG&amp;A to help offset higher costs and support profitability.
BofA Securities analyst Lorraine Hutchinson maintained the Buy rating on the stock, with a price forecast of $350.
According to Hutchinson, the increased order volatility driven by shifting tariffs could actually improve merchandise availability for the off-price sector.
She noted that Burlington&#8217;s direct sourcing exposure remains modest at 8%, mostly tied to categories like Home and gifting.
The analyst has modeled a flat gross margin for the second quarter. She anticipates 60 basis points of pressure on gross margin in the second half of the year as tariffs begin to flow through.
However, she suggested that mitigation strategies could offset this future pressure once Burlington and its vendors have had sufficient time to adjust their production processes and pricing structures.
The company has also seen strong comp performance at higher price points, with customers responding well to elevated merchandise. Hutchinson stressed that this trend will continue, especially as more price-sensitive consumers shift toward value options in response to broader retail price increases from tariffs.
Price Action: BURL shares are trading higher by 0.23% to $228.33 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high" target="_blank" rel="noreferrer noopener">Consumer Sentiment Stuck At 3-Year Lows As Inflation Fears Hit 44-Year High</a></li>
</ul>
Photo via Shutterstock

Analyst Ratings

BURL

Can Burlington's Profit Levers Deflect Tariff Impact? Analysts Weigh In

On Thursday, Best Buy Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) reported that first-quarter 2026 earnings&nbsp;<a href="https://www.benzinga.com/markets/equities/25/05/45592571/best-buy-q1-earnings-preview-analyst-flags-tariff-fallout-cuts-fy25-outlook-amid-profit-risk" target="_blank" rel="noreferrer noopener">fell short of expectations</a>.
The company's first-quarter sales fell around 1% (comparable sales fell 0.7%) year over year to $8.77 billion. They missed the analyst <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate of $9.22 billion.</a>
&#8220;Today we are updating our full year guidance to incorporate the impact of tariffs,&#8221; said Matt Bilunas, Best Buy CFO. The retailer now expects annual comparable sales growth to be up-or-down 1%. The adjusted operating income rate will likely be similar to last year at <a href="https://www.benzinga.com/news/earnings/25/05/45669267/best-buy-whiffs-on-sales-earnings-tariff-pressures-mount" target="_blank" rel="noreferrer noopener">approximately 4.2%</a>.
For Q2 FY26, Bilunas expects comparable sales to be slightly down to last year. He added that the company's adjusted operating income rate will be approximately 3.6.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44797563/goldman-sachs-sees-upside-in-retail-giants-dollar-tree-home-depot-best-buy-and-target-despite-tariff-margin-pressures" target="_blank" rel="noreferrer noopener">Goldman Sachs Sees Upside In Retail Giants Dollar Tree, Home Depot, Best Buy And Target</a>
Best Buy lowered its fiscal 2026 adjusted earnings from $6.20-$6.60 per share to $6.15-$6.30 per share versus consensus of $6.13 per share.
The company lowered its sales guidance from $41.4 billion to $42.2 billion to $41.1 billion to $41.9 billion. The consensus hovers around $41.44 billion. 
Guggenheim Securities writes: &#8220;We believe BBY&#8217;s 1Q 2025 operating results provide support behind our 2025 framework.&#8221; 
<ul class="wp-block-list">
<li>Analyst Steven Forbes reiterated the Buy rating and a price target of $90. Here&#8217;s what other </li>
</ul>
Wedbush on Friday lowered its price target from $75 to $70 while <a target="_blank" href="https://www.benzinga.com/quote/BBY/analyst-ratings" rel="noreferrer noopener">maintaining a Neutral rating</a>.
<ul class="wp-block-list">
<li>Analyst Matthew McCartney says the revised outlook embeds consumer behavior and remains relatively consistent through the year. Value-focused shoppers remain &#8220;willing to make big-ticket purchases if they need to or when they see compelling technology.&#8221; The firm expects a &#8220;much more compelling valuation <a href="https://www.benzinga.com/news/earnings/25/05/45669267/best-buy-whiffs-on-sales-earnings-tariff-pressures-mount">following Thursday&#8217;s sell-off</a>.&#8221; </li>
</ul>
Piper Sandler lowered its price target from $92 to $82 on Thursday, keeping an overweight rating.
<ul class="wp-block-list">
<li>Analyst Peter J. Keith writes, &#8220;To the positive, the impact from tariffs was less than expected and appears manageable &#8211; albeit with some price increases that could negatively impact consumer demand in 2H. For product innovation, while the new product pipeline has the Nintendo Switch 2 in June and discontinuing support for Windows 10 in October, the overall innovation outlook appears somewhat subdued.&#8221;</li>
</ul>
KeyBanc Capital Markets on Thursday wrote Best Buy&#8217;s Q1 results reflect continued headwinds within the consumer electronics industry. It reiterates the Sector Weight rating.
<ul class="wp-block-list">
<li>Analyst Bradley Thomas writes, &#8220;While we are encouraged with the updated guidance and management's initiatives, we believe there remains risk to comps in 2H as comparisons become more difficult and have uncertainty around demand destruction related to price increases.&#8221;</li>
</ul>
Truist Securities on Thursday reiterated Neutral rating on Best Buy, increasing the price target from $64 to $69 with a relatively balanced risk/reward.
<ul class="wp-block-list">
<li>Analyst Scot Ciccarelli writes, &#8220;Despite the benign projections on tariffs, sales momentum remains muted and we are looking at the 3rd straight yr of flattish earnings.&#8221;</li>
</ul>
Telsey Advisory on Friday wrote, &#8220;Although uncertainty remains with tariffs, given the ongoing court process governing their legality and negotiations between the US and other countries, we expect Best Buy to come out of the current environment on top within the consumer electronics space based on the company&#8217;s ability to leverage its scale and manage costs well.&#8221;
<ul class="wp-block-list">
<li>Analyst Joseph Feldman maintains an Outperform rating, with a price target of $90.</li>
</ul>
Price Action: BBY stock is up 0.36% at $66.56 at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45697301/shoe-carnival-stockpiles-inventory-to-dodge-tariffs-ramps-up-rebannering" target="_blank" rel="noreferrer noopener">Shoe Carnival Stockpiles Inventory To Dodge Tariffs, Ramps Up Rebannering</a></li>
</ul>
Image: Shutterstock

Analyst Color

Best Buy Falls Short As Shoppers Hold Off: Analysts Say Tariffs, Tech Slow Sales

Company will resume trading under its existing symbol "MINM"
HONG KONG, May 30, 2025 /PRNewswire/ -- FiEE, Inc. ("FiEE, Inc." or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that following a hearing before the Nasdaq Hearings Panel (the "Panel") on May 13, 2025, the Panel issued a decision on May 29, 2025, stating that Nasdaq will reinstate trading of the Company's common stock on the Nasdaq Capital Market at the open of business on Monday, June 2, 2025 under the ticker symbol "MINM".

MINM

FiEE Set To Resume Trading On Nasdaq Following Panel Decision

<h3 class="wp-block-heading">New On The Block</h3>
<ul class="wp-block-list">
<li>Revolution Beauty is putting itself in the shop window. The UK cosmetics brand has kicked off a formal sale process and is considering funding options as part of a broader strategic review, including a potential sale. Advisors are on board and talks with interested parties have begun. The news comes as CEO Lauren Brindley <a href="https://theindustry.beauty/revolution-beauty-ceo-lauren-brindley-exits/">departs</a> the company. Brindley, who became CEO in September 2023, <a href="https://www.benzinga.com/topic/beauty">accepted a leadership position</a> at Ulta Beauty Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>).</li>
</ul>
<ul class="wp-block-list">
<li>Also for sale: Apryse, a Denver-based document processing software provider, is on the auction block. Thoma Bravo hired Lazard to fetch a buyer willing to pay over $3 billion, according to Reuters.</li>
</ul>
<h3 class="wp-block-heading">Updates From The Block</h3>
<ul class="wp-block-list">
<li>E.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45677382/elf-beauty-buys-hailey-biebers-brand-rhode-for-1-billion-now-shes-richer-than-husband-justin-bieber">just made a billion-dollar bet</a> on lip gloss and blush. The company acquired Hailey Bieber's cosmetics brand, Rhode, for a cool $1 billion. And now Hailey officially out-earns her pop-star husband, Justin. Founded in 2022 and named after her middle name (and stylized with a lowercase "r"), the startup owes its hefty price tag to a Gen Z following and $212 million in sales in just the last year. </li>
<li>Acrisure lands a $2.1 billion investment from Bain Capital at a $32 billion valuation. The Michigan-based insurance giant raised fresh capital and is putting it to work—agreeing to acquire the payroll business of Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) for $1.1 billion.</li>
</ul>
<ul class="wp-block-list">
<li>According <a href="https://www.ft.com/content/f4d12c75-1a54-4d8c-8aa6-f863cbdc4aab">to</a> Financial Times, Hologic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) rejected an unsolicited $16 billion takeover bid from Blackstone and TPG. </li>
</ul>
<ul class="wp-block-list">
<li>MBK Partners, Northeast Asia&#8217;s largest private equity firm, is set to <a href="https://asia.nikkei.com/Business/Business-deals/Asian-private-equity-firm-MBK-wins-first-negotiation-rights-for-Makino">acquire</a> Japanese machine tool maker Makino Milling Machine in a deal estimated at over 2 trillion won ($1.75 billion). MBK has secured exclusive negotiation rights, beating out Carlyle Group, and plans to proceed via a tender offer at 11,000 yen per share. The same price was previously offered by Nidec in a hostile takeover attempt in April 2025, which was withdrawn in May due to Makino's resistance. The exact scope of MBK's tender offer hasn't been revealed. MBK will finance the acquisition using its sixth blind fund, launched in 2024. Makino, founded in 1937 and headquartered in Tokyo, is a global leader in precision machine tools. </li>
<li>Private equity firm H.I.G. Capital is set to take over Rentokil's French workwear division for $464 million. </li>
</ul>
<h3 class="wp-block-heading">Off The Block</h3>
<ul class="wp-block-list">
<li>E2open (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) is no longer for sale. The supply chain software firm just got picked up by Australia's WiseTech Global in a $2.1 billion deal. Shareholders will receive $3.30 a share in cold, hard cash—about 28% more than the stock's pre-announcement price and a whopping 68% premium over the closing stock price on April 30. <a href="https://www.benzinga.com/25/05/45612567/why-e2open-shares-are-trading-higher-by-25-here-are-20-stocks-moving-premarket">E2open&#8217;s shares rose</a> on the heels of the announcement and four <a href="https://www.benzinga.com/insights/analyst-ratings/25/05/45656183/4-analysts-assess-e2open-parent-holdings-what-you-need-to-know">analysts shared their evaluations</a>.</li>
</ul>
<ul class="wp-block-list">
<li>Energy company EOG Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) inked <a href="https://www.benzinga.com/cannabis/25/05/45693631/eog-strikes-5-6b-deal-to-expand-utica-footprint-boosts-dividend#google_vignette">a deal to acquire</a> Encino Acquisition Partners (EAP) for $5.6 billion, including EAP&#8217;s net debt. EOG agreed to pay the sellers, Canada Pension Plan Investment Board (CPP) and Encino Energy, with cash and debt. The purchase price includes $3.5 billion in new debt and $2.1 billion in cash. The company expects the transaction to close in the latter half of 2025, upon clearance under the Hart-Scott-Rodino Act.</li>
</ul>
<ul class="wp-block-list">
<li>Scopely has officially completed its $3.5 billion acquisition of Niantic's games business, according <a href="https://mobilegamer.biz/the-3-5bn-scopely-niantic-deal-has-officially-closed/">to</a> Mobile Gamer. The deal brings in over 400 new staff and a blockbuster portfolio that includes &#8220;Pokémon Go&#8221; and Wayfarer apps. The acquired titles collectively attracted more than 30 million monthly active users and generated over $1 billion in revenue last year. Announcing the deal&#8217;s close on May 29, Scopely emphasized its commitment to continuity, stating that longtime Niantic leaders Kei Kawai and Ed Wu will continue to lead the game teams, ensuring stability for Pokémon fans and other titles. Niantic's remaining titles, &#8220;Ingress&#8221; and &#8220;Peridot,&#8221; will remain under the newly formed Niantic Spatial, still led by CEO John Hanke. Scopely's co-CEOs hinted at more acquisitions ahead, noting they evaluated over 800 companies last year.</li>
</ul>
<h3 class="wp-block-heading">Bankruptcy Block</h3>
<ul class="wp-block-list">
<li>At Home, a home-goods retailer owned by private equity firm Hellman &amp; Friedman, is preparing to file for Chapter 11 bankruptcy. Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-05-27/retailer-at-home-prepares-to-file-for-bankruptcy-in-coming-weeks?sref=TBDibEcD">reported</a> that the company did not make its interest payment on May 15 and entered a forbearance pact with lenders on May 23, citing sources. The reprieve runs through June 30,</li>
</ul>
<ul class="wp-block-list">
<li>All 500 hand-scooped Thrifty Ice Cream counters inside Rite Aid locations are set to close. The beloved brand, founded in 1940, will still be available at some standalone shops and retailers. Rite Aid, which acquired the brand in 1996 and proudly served its signature cylindrical scoops across the West Coast, is now scooping out hundreds of store closures and looking to sell off assets as part of a <a href="https://abc7ny.com/post/rite-aid-stores-closing-drug-store-chain-close-300-more-locations-amid-bankruptcy/16588893/">bankruptcy</a> process, including Thrifty and its El Monte, California-based factory.</li>
</ul>
<ul class="wp-block-list">
<li>Everstream, a business-only fiber network, is selling most of its operations to stalking horse bidder Bluebird Fiber as part of a Chapter 11 bankruptcy auction. This follows earlier sales of its Illinois and St. Louis networks and plans to exit Pennsylvania. The sale to Bluebird includes most assets and comes with a $55 million lifeline in debtor-in-possession financing. Everstream remains open to better offers.</li>
</ul>
<h3 class="wp-block-heading">Notes From The Block</h3>
New data suggests that, after several volatile years, the behavioral health sector is regaining favor among strategic and financial buyers.
In the first quarter, 47 transactions were reported, including 34 mergers and acquisitions. That&#8217;s the highest M&amp;A volume since the fourth quarter of 2022, according to investment banker Kevin Taggart.
In <a href="https://www.mertztaggart.com/post/q1-2025-behavioral-health-m-a-report">a blog post</a> published this week, Taggart explained that renewed interest in the intellectual and developmental disabilities (I/DD) and autism segments was a key driver of the momentum. The firm tallied 12 transactions in Q1, the highest level since 2021.
Applied behavior analysis (ABA) therapy providers, in particular, are back in high demand. 
"The dust has seemed to settle" following the pandemic-era wage inflation and a wave of bankruptcies among large ABA providers, Taggart, a managing partner at Mertz Taggart, wrote. That shift has led to heightened buyer interest, especially in the wake of major exits.
The mental health subsector continues to show strong and steady deal flow, too. Twenty-nine transactions (19 M&amp;A and 10 growth investments) were announced in Q1, roughly matching the 30 deals reported in Q4 2024. 
Demand for psychiatric hospitals is particularly robust, though limited supply constrains deal volume. "We've had more groups ask us for psych hospitals since Q1 this year than probably any quarter in the last three or four years," Taggart said. "But there are fewer smaller operators out there."
Taggart also pointed to an ongoing trend: sustained investor appetite for high-valuation growth deals. "Money has continued to pour into these growth deals, which surprised us a bit," he said, signaling continued bullish sentiment across behavioral health verticals.
<a href="https://www.benzinga.com/top-stories/25/05/45593861/deal-dispatch-onlyfans-to-sell-for-8-billion-telecom-ma-heats-up-wolfspeed-on-road-to-bankruptcy">For last week&#8217;s edition of the Deal Dispatch, click here</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/05/45697983/consumer-sentiment-stuck-at-3-year-lows-as-inflation-fears-hit-44-year-high">Consumer Sentiment Stuck At 3-Year Lows As Inflation Fears Hit 44-Year High</a></li>
</ul>
Image created using a photo from Shutterstock

Gaming

ETWO

HOLX

ULTA

Deal Dispatch: Beauty Brand Seeks Pretty Price Tag, Behavioral Health Firms Hit Auction Block

Politics

General

Reuters Reports Japan Economy Minister Akazawa Reportedly Says, Difficult To Agree To A Deal If U.S. Does Not Agree To Drop All Tariffs, Including Reciprocal And Auto Tariffs

WIIM

AMAT

ASML

AVGO

INTC

KLAC

LEDS

LRCX

LSCC

MCHP

NXPI

QCOM

RMBS

SIMO

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSEM

Shares of chip stocks are trading lower amid reports indicating the Trump administration is planning wider China tech restrictions.

Rumors

Trading Ideas

CVLT

Watching Commvault Systems; Hearing Investor Business Daily's SwingTrader Picks Stock

Reuters Reports Japan Economy Minister Akazawa Reportedly Says Agreed To Accelerate Trade Talks With U.S. Ahead Of G7 Summit; Nothing Is Agreed Until Everything Is Agreed; Economic Security Cooperation Comes Up On Agenda Every Meeting; Rare Earth, Other Key Minerals Among Important Economic Security Topics; No Change In Stance That Tariffs, Including Those On Auto Parts, Regrettable; Aim To Complement U.S., Japan Strengths In Chips

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4439265-1&amp;h=850002258&amp;u=https%3A%2F%2Fwww.davita.com%2F&amp;a=DaVita">DaVita</a>, a comprehensive kidney care company, issued the following statement in response to&nbsp;updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita.
"As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."

DaVita Supports One-Year Extension of Kidney Care Choices Model, Citing Long-Term Savings and Improved Patient Outcomes

Major indexes are lower amid US-China trade uncertainty after President Trump on social media said China has violated its agreement and federal appeals court on Thursday temporarily reinstated most of the tariffs imposed by Trump. Additionally, the Trump administration reportedly plans tech sector restrictions.

<a href="https://www.semafor.com/article/05/30/2025/california-opens-inquiry-into-paramount-and-trump">https://www.semafor.com/article/05/30/2025/california-opens-inquiry-into-paramount-and-trump</a>

PARA

'California opens inquiry into Paramount and Trump'- Semafor

<a href="https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/" title="https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/">https://www.washingtonpost.com/health/2025/05/30/covid-vaccines-children-pregnant-women/</a>

Biotech

BNTX

MRNA

NVAX

'Contradicting RFK Jr., CDC keeps recommending covid vaccine for kids' - Washington Post

The iShares China Large-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>), which tracks the performance of 50 of the largest Chinese companies listed in Hong Kong, fell 1.91% to $34.94 on Friday afternoon, under pressure from renewed U.S.-China trade tensions and broad market weakness.
A federal appeals court <a href="https://www.benzinga.com/markets/market-summary/25/05/45689974/us-stocks-likely-to-open-lower-as-appeals-court-temporarily-reinstates-tariffs-the-market-hate-uncertainty-says-expert">temporarily reinstated</a> most of the recent tariffs imposed by President&nbsp;Donald Trump, pausing a lower court ruling that had invalidated them. The stay allows the administration to continue its appeal, further stoking U.S.-China trade tensions.
What To Know: Friday&#8217;s decline also comes as President Donald Trump <a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">accused</a> China of "totally" breaching a prior tariff agreement, sparking fresh fears of a trade war resurgence. Reports indicate the White House is preparing expanded tech sanctions, potentially targeting companies with indirect links to already-sanctioned entities.
These geopolitical jitters weighed heavily on global markets. The S&amp;P 500 lost 1% and the Nasdaq-100 dropped 1.3%, with only defensive sectors managing gains.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/05/45701546/whats-going-on-with-trump-media-shares-today">What&#8217;s Going On With Trump Media Shares Today?</a>
Economic data <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">added</a> to investor uncertainty. While the Fed's preferred inflation gauge, the core PCE index, cooled to 2.5% year-over-year in April, suggesting subdued price pressures, consumer spending growth slowed sharply to 0.2%, signaling softening demand. 
At the same time, consumer sentiment remained at a three-year low, and inflation expectations for the next year surged to 4.5%. FXI&#8217;s sharp drop Friday reflects investor anxiety over both external trade risks and internal U.S. economic fragility, as sentiment shifted away from risk assets heading into the weekend.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45700679/rivian-rivn-stock-is-volatile-whats-going-on">Rivian Stock Is Volatile: What&#8217;s Going On?</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, FXI has a 52-week high of $38.73 and a 52-week low of $24.59.
Image: Shutterstock

iShares China Large-Cap ETF (FXI) Drops As Trade Tensions Resurface, Economic Data Sends Mixed Signals

When a 65-year-old woman named Dottie wrote in to Suze Orman's "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-will-i-really-be-able-to-retire">Women &amp; Money</a>" podcast, she was looking for reassurance about her retirement savings. What she got was much more: a strong reminder that financial success is about more than just the numbers in your bank account.
Here's what Dottie shared — and why Orman believes her situation is stronger than she thinks.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">A Snapshot of Dottie's Finances</h2>
Dottie described herself as a newly single 65-year-old woman in good health. She works part time and brings in about $3,000 a month from her job, along with $1,600 in <a href="https://www.benzinga.com/25/05/45521151/4000-senior-bonus-tax-break-proposed-but-critics-say-its-a-consolation-prize-for-broken-social-security-promises">Social Security</a>. She plans to continue working for another three to four years.
Her savings include:
<ul class="wp-block-list">
<li>$350,000 in certificates of deposit</li>
<li>$250,000 in an IRA</li>
</ul>
She owns her car outright, has no debt, and although she rents, her living expenses are low. She even makes sure to enjoy herself and spend on fun activities.
Her question for Orman was simple: "How far behind am I in retirement savings at this stage?"
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">Suze Orman: "You Are So Far Ahead"</h2>
Orman's response was immediate and enthusiastic.
"Oh, Dottie," she began, "it's not how far behind you are in retirement savings at this stage. It's how far behind you happen to be in comparing yourself to others."
<a href="https://www.benzinga.com/personal-finance/25/05/45587754/i-contributed-after-tax-amounts-to-a-pre-tax-ira-can-i-withdraw-those-contributions-to-open-a-roth-account-heres-what-suze-orman-says">Orman</a> explained that many people judge their financial situation by comparing it to others — those who appear wealthier or live more extravagantly. But appearances can be deceiving. Someone might own multiple homes and drive a luxury car, but still be drowning in debt.
"You, my dear, are so far ahead," Orman said. "You have no debt. You own your car outright. You have $250,000 in your IRA. You have $350,000 in CDs, and you're going to get Social Security. Are you kidding me? You are going to be just fine as long as your expenses are always less than the money that you have coming in."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Why Debt — Not Income — Tells the Real Story</h2>
Throughout her career, Orman has emphasized a key lesson: your expenses matter more than your income. It's not about how much you earn or have saved — it's about what that money needs to cover.
To illustrate her point, Orman recalled her experience doing <a href="https://www.benzinga.com/25/05/45256709/approaching-retirement-suze-ormans-2025-plan-for-safe-high-earning-cash">retirement planning</a> for Pacific Gas and Electric employees. She noted that workers with modest pensions and small savings often fared better in retirement than high-earning executives with multiple homes, expensive cars, and constant financial pressure.
<h2 class="wp-block-heading">A Reminder for Anyone Nearing Retirement</h2>
For those approaching retirement, Orman's message is clear: don't measure your financial health against others. Instead, focus on your own expenses, your savings, and whether your income will reliably cover your needs.
"You are not behind," Orman told Dottie. "You are ahead of most everybody out there."
As long as Dottie keeps her expenses lower than her income — and continues to live within her means — Orman believes she's on track for a comfortable retirement.
Read Next:
<ul class="wp-block-list">
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Suze Orman Tells 65-Year-Old With $600K Savings And No Debt: 'You Are So Far Ahead'

<a href="https://www.benzinga.com/personal-finance/25/03/44438885/charlie-munger-told-a-20-year-old-that-getting-rich-through-investing-is-damn-near-impossible-and-you-might-need-10-million-in-the-bank">Charlie Munger</a> lived near Paramount Studios—and never once took the bait. While others got starstruck by Hollywood, he stayed unimpressed and uninvested. At the 2023 Daily Journal meeting, months before his passing, Munger didn't just dodge questions. He dropped truth bombs.
By then, he'd seen it all: the Great Depression, tech booms, dot-com busts, and Bitcoin hype. But nothing rattled him quite like showbiz.
So when CNBC's Becky Quick <a href="https://www.benzinga.com/personal-finance/25/04/44939515/charlie-munger-was-asked-if-disney-was-still-a-good-investment-they-once-owned-the-world-now-its-a-bloodbath-welcome-to-human-life">asked him about Disney</a>, she got the kind of answer only Munger could give.
"Practically every business that Disney has has gotten tougher than it used to be," he said. "Again, welcome to human life."
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
That's how he opened. No dramatic buildup. Just a clear, cold observation: nothing stays easy forever—not even for a company that once "owned the world," as Munger put it. He recalled Disney's era of dominance—"The Lion King" conquering Broadway, content triumphs stacking up, victory after victory.
"They went from triumph to triumph, marching, marching, marching," he said. "All of a sudden, on practically every front, it's more difficult. This is what happens."
Munger wasn't writing Disney off. He noted the company still had real assets. But he didn't sugarcoat what they're up against. "How would you like running the sports, ESPN, now at Disney compared to its heyday?" he asked. "It's going to be way harder for them."
Even the movie business, he warned, looked grim. "Movies look, to me, like it's going to be a bloodbath, too. It's not a bit easy."
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
That wasn't nostalgia talking. It was analysis. "In the heyday of ESPN, Disney made nothing but money out of ESPN. It was a total goldmine," he said.&nbsp;
When the conversation shifted to Paramount—a large Berkshire holding at the time—Munger distanced himself fast. "I live within a few blocks from Paramount Studios and I don't even know anybody at Paramount," he said. "I have avoided the movies like the plague as an investor all my life."
He was just getting started.
"I've never made an investment in the movie business in any way, shape, or form. It always gives me the willies," he said. Then came the Munger rundown: "I don't like the unions, I don't like the crazy agents, I don't like the goddamn crazy lawyers, I don't like the crazy movie stars."
Even after his passing, his instincts seemed to echo. At the 2024 Berkshire Hathaway shareholder meeting, <a href="https://www.cnbc.com/2024/05/04/buffett-says-berkshire-sold-its-entire-paramount-stake-we-lost-quite-a-bit-of-money.html">Warren Buffett revealed</a> he had finally pulled the plug on Paramount —and paid the price.
"I was 100% responsible for the Paramount decision," Buffett admitted. "It was 100% my decision, and we've sold it all and we lost quite a bit of money."
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
While Munger had taken a lifelong stance against Hollywood, Buffett took a position—then an exit.&nbsp;
For Munger, it wasn't just the numbers—it was the culture. "Everything about it is not my culture," he said. "I liked those old English actors when they came over. I grew up with them. But, basically, movies are not my scene, so I've avoided it."
He wasn't against performers or artists making a living. "It may be a very good place to make a living as an actor or a writer or a musician," he allowed. "But it's a hard place to make money if you're an investor."
Munger never had time for chaos, hype, or industries run on personalities and promises. He wanted a margin of safety, cash flow, and predictability—and for him, the movie business had none of it.
Even in his final year, he kept doing what made him a legend: stripping things down to what they really were—and walking away when they didn't make sense.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Charlie Munger Snubbed Paramount And Hollywood: 'I Don't Like The Unions, Agents, Lawyers, Or The Crazy Movie Stars —Always Gives Me The Willies'

Knowing what to do with a 401(k) after leaving a job can feel overwhelming — especially for younger workers planning long-term. That's why a listener named Robert reached out to Suze Orman's "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-will-i-really-be-able-to-retire">Women &amp; Money</a>" podcast for guidance on what to do with his Roth 401(k) if he ever leaves his company.
Robert, 38, said he's been with his employer for 12 years and doesn't plan to leave anytime soon. Still, he wondered if he ever leaves his job, should he eventually roll his money into a Roth IRA, move it into a new employer's Roth 401(k), or just leave it where it is?
Here's what Orman had to say — and the one move she advised him to avoid.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Suze Orman: Skip the Roth 401(k) at Your New Job</h2>
Orman didn't offer a one-size-fits-all answer but made it clear that one option was off the table.&nbsp;
"Should you roll the money into a Roth 401(k) at a new company? No," she said. Instead, she encouraged Robert to either leave the money in his current <a href="https://www.benzinga.com/personal-finance/25/04/44889415/90-of-plans-offer-it-but-only-20-use-it-suze-orman-says-this-401k-feature-is-being-ignored-at-your-own-risk">Roth 401(k)</a> or roll it into a Roth IRA, depending on what he feels most comfortable with at the time.
Her reasoning? Over time, Robert could accumulate a large balance in his 401(k), possibly a million dollars or more. Liquidating and transferring that amount later might feel daunting, especially if he's unfamiliar with investment options in the new plan.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">Comparing the Options: Stay Put or Roll Over?</h2>
If Robert leaves his job, he'll typically have four options: cash out, leave the money in his old plan, roll it into a Roth IRA, or roll it into a new employer's Roth 401(k). Orman ruled out that last option, so let's look closer at the two she suggested.
Leaving the Money in Your Roth 401(k)
If the current 401(k) plan offers low-cost investment options and solid performance, leaving the funds where they are could make sense. In her <a href="https://www.suzeorman.com/blog/Retirement-Account-Rollovers-What-to-Consider">blog</a>, Orman mentions that larger companies often negotiate lower fees — sometimes under 0.20% in expense ratios — which can help preserve returns over time.
The downside? You'll have to manage multiple accounts if you <a href="https://www.benzinga.com/personal-finance/25/03/44567830/suze-orman-warns-this-401k-mistake-when-switching-jobs-could-cost-you-300000">switch employers</a> later. That can make retirement planning more complex down the road.
Rolling Into a Roth IRA
The other path Orman supports is rolling the funds into a Roth IRA. This option can give you greater control over your investments and simplify your portfolio if you're managing several old accounts.&nbsp;
But beware: as a<a href="https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2022/06/small-differences-in-mutual-fund-fees-can-cut-billions-from-americans-retirement-savings"> Pew Research study</a> highlights, some IRA versions of the same funds found in a 401(k) can carry higher fees, which can cost investors thousands over time if not carefully managed.
To keep costs low, Orman recommends using discount brokerages and investing in low-cost index funds or ETFs.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">What to Watch Out For</h2>
While rolling over your 401(k) can streamline your retirement accounts, there are some pitfalls to avoid:
<ul class="wp-block-list">
<li>Indirect Rollovers: These involve receiving a check and reinvesting the money yourself within 60 days. If you miss the deadline, you may face taxes and penalties.</li>
<li>Higher Fees: Not all IRAs are created equal. Make sure to research expense ratios and investment options before making a move.</li>
<li>Losing Employer-Only Investment Options: Some 401(k) plans include investment choices you won't find in an IRA or new employer's plan.</li>
</ul>
<h2 class="wp-block-heading">The Bottom Line</h2>
For Robert — and anyone considering what to do with their Roth 401(k) — the best choice depends on comfort level, investment familiarity, and fees. Orman's guidance is clear: Avoid rolling it into a new employer's plan. Instead, evaluate whether to keep it where it is or roll it into a low-cost <a href="https://www.benzinga.com/personal-finance/25/04/44656837/build-your-retirement-portfolio-while-saving-for-emergencies-a-roth-ira-can-double-as-an-emergency-fund-is-that-true">Roth IRA</a> that gives you more control and flexibility.
As always, it pays to compare your options carefully before making a decision.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

38-Year-Old Asks Suze Orman Where To Move His Roth 401(k) — She Says Avoid This One Option

Press Releases

Savara Announces New Employment Inducement Grant

Penny Stocks

Small Cap

Savara Announces Participation in the Upcoming Citizens Life Sciences Conference

Savara Announces Participation in the H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference

Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic Society Conference (ATS) 2025

Savara Announces Participation in Jefferies Global Healthcare Conference

Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP)

Legal

BREAKING: Savara Shares Down Over 30%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

INVESTOR ALERT: Investigation of Savara Inc. (SVRA) Announced by Holzer & Holzer, LLC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA

Comments

Savara

Actualités

Dernières nouvelles pour Savara (NASDAQ:SVRA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL